You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君實生物(01877.HK):科創板上市申請審核狀態為"已問詢"
格隆匯 02-20 20:43

格隆匯2月20日丨君實生物-B(01877.HK)公告,上海君實生物醫藥科技股份有限公司(以下簡稱“公司”)擬首次公開發行股票並上市,2019年4月25日,公司向中國證券監督管理委員會上海監管局提交上市輔導並獲受理,輔導機構為中國國際金融股份有限公司。

2019年9月16日,公司在中國國際金融股份有限公司的輔導下,已通過中國證券監督管理委員會上海監管局的輔導驗收。

公司在中止審核期間已完成相關財務數據的更新,並於2020年2月18日向上交所提交了恢復審核申請,上交所同意自2020年2月20日起恢復對公司發行上市的審核。

目前,公司首次公開發行股票並在科創板上市申請的審核狀態為“已問詢”。公司將根據相關事項進展情況嚴格按照法律法規的規定和要求,及時履行信息披露義務,敬請廣大投資者關注,並注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account